Radionetics – Talk Bio

Actionable Insights Powered by AI

Lilly Secures Option to Acquire Radionetics for $1 Billion in Radiopharma Deal

Eli Lilly, Radionetics Oncology, Radiopharmaceuticals, G Protein-Coupled Receptors, Solid Tumors, Biotechnology, Acquisition